Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management

Ali Abdolrahmani,Joel B. Epstein,Firoozeh Samim
DOI: https://doi.org/10.1007/s00520-024-08388-4
IF: 3.1
2024-03-06
Supportive Care in Cancer
Abstract:Medication-related osteonecrosis of the jaw (MRONJ) is a debilitating side effect of antiresorptive and antiangiogenic agents that can lead to progressive bone destruction in the maxillofacial region. Dental surgery, including tooth extractions, commonly trigger the onset of MRONJ. While guidelines suggest avoiding extraction when possible, complete avoidance is not always feasible, as necrosis can develop from dental and periodontal disease without dental procedures. The goal of this article is to provide an update review of current preventive and therapeutic approaches for MRONJ.
oncology,health care sciences & services,rehabilitation
What problem does this paper attempt to address?